Perspectives

We sat down with Nick Sireau - CEO of the AKU Society, a rare disease advocacy group, and a member of the Lumanity Expert Patient Council - to talk about the challenges facing the rare disease community.

Lumanity’s Suzette Matthijsse (Director and EU Head of Health Economics Analysis) shares key learnings from the the European Commission meeting.

In this MM+M sponsored podcast, Marc Iskowitz, editor-at-large of MM+M, spoke with Lumanity Creative Strategy’s Michael Parisi, global president, and Marissa Poli, head of workflow, about how Guidemark Health, an agency that specializes in oncology and rare disease, is entering a new phase.